New contact lens aims to soothe Sjögren's dry eye
NCT ID NCT07185139
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This early study tests a special contact lens (MSCohi-O) for people with Sjögren's syndrome whose dry eyes don't improve with standard treatments. Twelve participants will wear the lenses for 12 hours a day over 14 sessions. Researchers will check for side effects and measure changes in eye health and comfort.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- MSCohi-O Lenses (a drug-coated contact lens)
- What this could lead to
- If it works, this could point toward a new way to manage severe dry eye in Sjögren's syndrome without daily eye drops.
- What could go wrong
- This is a very early, tiny trial (12 people) with no comparison group. It only tests short-term use, so success is far from guaranteed.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SJÖGREN'S SYNDROME are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Experimental CAR-T injection aims to tame autoimmune diseases
- Engineered immune cells take aim at autoimmune diseases
- Engineered immune cells aim to tame childhood arthritis and lupus
- New cell therapy hopes to tame tough autoimmune diseases
- Experimental CAR t therapy takes on autoimmune diseases
- Could a simple ingredient boost dry eye drops?